This is a preview of subscription content, log in via an institution to check access.
Reference
Hayashi N, et al. Real-world safety and effectiveness of adalimumab in patients with hidradenitis suppurativa: A 52-week analysis of a postmarketing surveillance study in Japan. Journal of Dermatology 50 : 1034-1044, No. 8, Aug 2023. Available from: URL: http://doi.org/10.1111/1346-8138.16835
Rights and permissions
About this article
Cite this article
Adalimumab. Reactions Weekly 1977, 17 (2023). https://doi.org/10.1007/s40278-023-47091-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-023-47091-5